Using this approach, genes S100A8, IFI27, CLU, IFITM3, and MT-CO1 have been identified as the stable gene panel for the classification of severe COVID-19 patients, utilizing the same training dataset as previously employed (Fig. 8b). This evidence concerns the gene S100A8 and COVID-19.